Novo Nordisk’s big US-based competitor, Eli Lilly, has exceeded the sales expectations of its leading diabetes type 2 drug, just as its Danish counterpart could announce the same thing in its financial report on Wednesday.
Sales of the GLP 1 drug Trulicity, which is in direct competition with Novo Nordisk’s Ozempic and its predecessor Victoza, grew by 25 percent to USD 1.9bn in the fourth quarter of 2021, the company’s full-year financial figures show on Thursday. Analysts asked by Bloomberg only predicted an increase to USD 1.78bn prior to the report.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Director Global Engineering 
IRT Manager, Clinical Drug Supply 
Laboratory technician for process development and clinical manufacturing 
Senior QA Specialist 
Client Talent Acquisition Specialist 
Account Manager 
Senior Project Manager (GMP - Life Science) 
Analytical Coordinator for Analytical Development 
Strategic Procurement Manager, Direct Spend (Category Manager) 
Clinical Trial Manager 
(Senior) Drug Substance Specialist 
Consultant Manager 
Nordic Medical Affairs Manager 
Clinical Trial Manager for development of in vitro diagnostics 
Communications Consultant 
Director for innovative pre-clinical testing unit 
Production Director 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
System Sales Development Consultant - Investment Projects, Merck Millipore